Jasbir Seehra
Chief Executive Officer chez KEROS THERAPEUTICS, INC.
Fortune : 17 M $ au 31/03/2024
Profil
Jasbir S.
Seehra was the founder of Acceleron Pharma, Inc. (founded in 2004) where he held the title of Chief Scientific Officer & Senior Vice President from 2004 to 2010.
He is currently the President, Chief Executive Officer & Director at Keros Therapeutics, Inc. since 2015.
In his former positions, he served as an Independent Director at Eloxx Pharmaceuticals, Inc. from 2018 to 2022.
He also held positions as Vice President at Wyeth LLC, Principal at Genetics Institute LLC, Principal at AVEO Pharmaceuticals, Inc., Chief Scientific Officer at Ember Therapeutics, Inc. from 2011 to 2015, and Vice President-Biological Chemistry at Wyeth Pharmaceuticals, Inc. Dr. Seehra obtained his undergraduate and doctorate degrees from The University of Southampton.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KEROS THERAPEUTICS, INC.
0,70% | 23/02/2024 | 252 856 ( 0,70% ) | 17 M $ | 31/03/2024 |
Postes actifs de Jasbir Seehra
| Sociétés | Poste | Début |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Chief Executive Officer | 01/12/2015 |
Anciens postes connus de Jasbir Seehra
| Sociétés | Poste | Fin |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Director/Board Member | 28/06/2022 |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 01/04/2015 |
| ACCELERON PHARMA INC. | Founder | 01/11/2010 |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Corporate Officer/Principal | - |
| AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Jasbir Seehra
| The University of Southampton | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KEROS THERAPEUTICS, INC. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Health Technology |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
